NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Feb. 27, 2006--BrainStorm Cell Therapeutics (OTCBB: BCLI), the developer of NurOwn(TM) bone marrow derived stem cell therapeutic products for the treatment of neurodegenerative diseases, announced today that a cover story article about BrainStorm appears in the Vol.6 Issue 1 edition of BioIsrael, a magazine covering Israeli biotechnology. The article is titled "Stem Cells Bring New Business Models: BrainStorm Beefs Up Revenue-Sharing With Hospitals" and includes an interview with Yoram Drucker, Chief Operations Officer and Principal Executive of BrainStorm. The article may be viewed at www.bioisrael.com
